Search Results - "Basak, G."

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) by Hayden, P.J., Roddie, C., Bader, P., Basak, G.W., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M.J., Köhl, U., Kuball, J., Mielke, S., Mohty, M., Murray, J., Nagler, A., Rees, J., Rioufol, C., Saccardi, R., Snowden, J.A., Styczynski, J., Subklewe, M., Thieblemont, C., Topp, M., Ispizua, Á.U., Chen, D., Vrhovac, R., Gribben, J.G., Kröger, N., Einsele, H., Yakoub-Agha, I.

“…Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) products targeting CD19 have been approved in Europe for…”
Get full text

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation by Mohty, M, Hübel, K, Kröger, N, Aljurf, M, Apperley, J, Basak, G W, Bazarbachi, A, Douglas, K, Gabriel, I, Garderet, L, Geraldes, C, Jaksic, O, Kattan, M W, Koristek, Z, Lanza, F, Lemoli, R M, Mendeleeva, L, Mikala, G, Mikhailova, N, Nagler, A, Schouten, H C, Selleslag, D, Suciu, S, Sureda, A, Worel, N, Wuchter, P, Chabannon, C, Duarte, R F

“…Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with multiple myeloma or lymphoma after myeloablative…”
Get full text

Secondary solid cancer screening following hematopoietic cell transplantation by Inamoto, Y, Shah, N N, Savani, B N, Shaw, B E, Abraham, A A, Ahmed, I A, Akpek, G, Atsuta, Y, Baker, K S, Basak, G W, Bitan, M, DeFilipp, Z, Gregory, T K, Greinix, H T, Hamadani, M, Hamilton, B K, Hayashi, R J, Jacobsohn, D A, Kamble, R T, Kasow, K A, Khera, N, Lazarus, H M, Malone, A K, Lupo-Stanghellini, M T, Margossian, S P, Muffly, L S, Norkin, M, Ramanathan, M, Salooja, N, Schoemans, H, Wingard, J R, Wirk, B, Wood, W A, Yong, A, Duncan, C N, Flowers, M E D, Majhail, N S

“…Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and…”
Get full text

The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760 by Cacanyiova, Sona, Cebova, Martina, Simko, Fedor, Baka, Tomas, Bernatova, Iveta, Kluknavsky, Michal, Zorad, Stefan, Krskova, Katarina, Shaman, Ezgi, Zemancikova, Anna, Barta, Andrej, Aydemir, Basak G, Berenyiova, Andrea

“…Abstract Background Angiotensin converting enzyme 2 (ACE2) plays a crucial role in the infection cycle of SARS-CoV-2 responsible for formation of COVID-19…”
Get full text

Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1 by Abdelbaset-Ismail, A, Borkowska-Rzeszotek, S, Kubis, E, Bujko, K, Brzeźniakiewicz-Janus, K, Bolkun, L, Kloczko, J, Moniuszko, M, Basak, G W, Wiktor-Jedrzejczak, W, Ratajczak, M Z

“…As a crucial arm of innate immunity, the complement cascade (ComC) is involved both in mobilization of normal hematopoietic stem/progenitor cells (HSPCs) from…”
Get full text

Seasonal effect on the prevalence of virulence genes of non-O157 Verotoxic E.coli serogroups in faeces of cattle calves by PARUL, BIST, B, SHARMA, B, KUMAR, A, SINGH, S P, JAIN, U, GOSWAMI, M, MISHRA, R P, BASAK, G

“…Calves faecal samples (n=216) were investigated to observe the effect of seasons on the prevalence of serogroups and virulence genes of non-O157 VTEC. A total…”
Get full text

CAR-T cells: the narrow path between hope and bankruptcy? by Chabannon, C, Kuball, J, Mcgrath, E, Bader, P, Dufour, C, Lankester, A, Basak, G W, Montoto, S, Nagler, A, Snowden, J A, Styczynski, J, Duarte, R F, Kröger, N, Mohty, M

Get full text

Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT–NCI Chronic GVHD Task Force by Duarte, R F, Greinix, H, Rabin, B, Mitchell, S A, Basak, G, Wolff, D, Madrigal, J A, Pavletic, S Z, Lee, S J

“…In 2005, the National Institutes of Health (NIH) consensus conference published a series of papers recommending methods to improve the conduct of clinical…”
Get full text

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization by Hübel, K, Fresen, M M, Apperley, J F, Basak, G W, Douglas, K W, Gabriel, I H, Geraldes, C, Jaksic, O, Koristek, Z, Kröger, N, Lanza, F, Lemoli, R M, Mikala, G, Selleslag, D, Worel, N, Mohty, M, Duarte, R F

“…The effectiveness of the novel hematopoietic stem cell mobilizing agent plerixafor was evaluated in nationwide compassionate use programs in 13 European…”
Get full text

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study by Mussetti, A., Rius-Sansalvador, B., Moreno, V., Peczynski, C., Polge, E., Galimard, J. E., Kröger, N., Blaise, D., Peffault de Latour, R., Kulagin, A., Mousavi, A., Stelljes, M., Hamladji, R. M., Middeke, J. M., Salmenniemi, U., Sengeloev, H., Forcade, E., Platzbecker, U., Reményi, P., Angelucci, E., Chevallier, P., Yakoub-Agha, I., Craddock, C., Ciceri, F., Schroeder, T., Aljurf, M., Ch, Koenecke, Moiseev, I., Penack, O., Schoemans, H., Mohty, M., Glass, B., Sureda, A., Basak, G., Peric, Z.

“…Allogeneic haematopoietic cell transplantation (alloHCT) has curative potential counterbalanced by its toxicity. Prognostic scores fail to include current era…”
Get full text

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study by Greenfield, D. M., Salooja, N., Peczynski, C., van der Werf, S., Schoemans, H., Hill, K., Cortelezzi, A., Lupo-Stangellini, M., Özkurt, Z. N., Arat, M., Metzner, B., Turlure, P., Rovo, A., Socié, G., Mohty, M., Nagler, A., Kröger, N., Dreger, P., Labopin, M., Han, T. S., Tichelli, A., Duarte, R., Basak, G., Snowden, J. A.

“…Metabolic syndrome (MetS) is associated with cardiovascular disease in the general population and is also a potential cardiovascular risk factor in survivors…”
Get full text

Pericarditis in Patients With Chronic Graft-vs-Host Disease by Karakulska-Prystupiuk, E., Basak, G., Dwilewicz-Trojaczek, J., Paluszewska, M., Boguradzki, P., Jędrzejczak, W.

“…There are only a few cases of pericarditis complications following allogeneic bone marrow transplantation described in the literature and there are no data…”
Get full text

ARTIFICIAL INTELLIGENCE-BASED ALGORITHM FOR THE DIAGNOSIS OF IDIOPATHIC MULTICENTRIC CASTLEMAN'S DISEASE IN A LOWER-MIDDLE INCOME COUNTRY by AAGS Brandão, D Leão, M Konopelko, W Amtmaski, G Basak, BM Verboski, CL Assunção, K Lis, MJ Dabrowski, M Dudziski

“…Introduction: Idiopathic multicentric Castleman's disease (iMCD) is an ultra rare lymphoproliferative disorder difficult to diagnose due to its rarity…”
Get full text

Azacitidine for Relapse After Allogeneic Stem Cell Transplantation—Single-Center Study by Karakulska-Prystupiuk, E., Drozd-Sokołowska, J., Waszczuk-Gajda, A., Stefaniak, A., Dwilewicz-Trojaczek, J., Kulikowska, A., Chmarzyńska-Mróz, E., Basak, G., Paluszewska, M., Boguradzki, P., Jędrzejczak, W.

“…Relapse is the leading cause of treatment failure for myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation. Treatment options…”
Get full text

The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis by Ruutu, T, Gratwohl, A, Niederwieser, D, de Witte, T, van der Werf, S, van Biezen, A, Mohty, M, Kröger, N, Rambaldi, A, McGrath, E, Sureda, A, Basak, G, Greinix, H, Duarte, R F

“…In 2013, recommendations for a standardized practice in the prophylaxis and treatment of GvHD were adopted and published by the European Society for Blood and…”
Get full text

Update on the Incidence of Metamizole Sodium-Induced Blood Dyscrasias in Poland by Basak, GW, Drozd-Sokołowska, J, Wiktor-Jedrzejczak, W

“…Metamizole sodium (metamizole) is a popular non-opioid analgesic and a common non-prescription product in Poland. Controversy exists regarding the level of…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT by Basak, G. W., Wiktor‐Jedrzejczak, W., Labopin, M., Schoemans, H., Ljungman, P., Kobbe, G., Beguin, Y., Lang, P., Koenecke, C., Sykora, K. W., te Boome, L., van Biezen, A., van der Werf, S., Mohty, M., de Witte, T., Marsh, J., Dreger, P., Kröger, N., Duarte, R., Ruutu, T.

“…We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic…”
Get full text

Management of growth failure and growth hormone deficiency after pediatric allogeneic HSCT: Endocrinologists are of importance for further guidelines and studies by Lawitschka, A., Schwarze, P., Rovelli, A., Badoglio, M., Socie, G., Tichelli, A., Bauer, D., Rovo, A., Basak, G., Schoemans, H., Peters, C., Salooja, N.

“…Growth failure (GF) is a frequent problem after pediatric allogeneic hematopoietic stem cell transplantation (HSCT). Growth hormone deficiency (GHD) occurs in…”
Get full text

Azacitidine Use After Allogeneic Stem Cell Transplantation—Results From the Polish Adult Leukemia Group by Drozd-Sokołowska, J, Gil, L, Waszczuk-Gajda, A, Mądry, K, Piekarska, A, Dutka, M, Basak, G.W, Karakulska-Prystupiuk, E, Dwilewicz-Trojaczek, J

“…Abstract Background Relapse of primary hematologic disease constitutes an important reason for failure of allogeneic hematopoietic stem cell transplantation…”
Get full text

PB1921: A RANDOMIZED, DOUBLE‐BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA‐POSITIVE HR‐MDS (SELECT‐MDS‐1) by DeZern, A., Marconi, G., Deeren, D., Diez Campelo, M., Lübbert, M., Krishnamurthy, P., Nagy, Z., Basak, G., Jonášová, A., Morozova, E., Geissler, K., Ofran, Y., Kelley, H., Volkert, A., Baker, K., Kang‐Fortner, Q., Hodgson, G., Madigan, C., Roth, D. A., Kelly, M., Fenaux, P.

Get full text